Table 1 Baseline Characteristics
Age (years) | 63.6 ± 12.6 |
Male, n (%) | 41 (76) |
Indication for ICD, n (%) | |
1o | 41 (76) |
2o | 13 (24) |
Ischemic HF, n (%) | 32 (59) |
LVEF, n (%) | |
30–39 | 16 (30) |
20–29 | 24 (44) |
< 20% | 14 (26) |
Comorbidities, n (%) | |
Hypertension | 29 (54) |
Dyslipidemia | 30 (56) |
Diabetes | 20 (37) |
Device, n (%) | |
Medtronic | 15 (28) |
St. Jude | 34 (63) |
Boston | 4 (7) |
Biotronik | 1 (2) |
Dual chamber, n (%) | 36 (67) |
CRT, n (%) | 22 (41) |
Paced> 1%, n (%) | 19 (35) |
Mean time paced | 6.6% |
Atrial fibrillation history, n (%) | 16 (30) |
Atrial fibrillation on interrogation, n (%) | 15 (28) |
History of VT/VF, n (%) | 30 (56) |
VT on interrogation, n (%) | 6 (11) |
NSVT on interrogation, n (%) | 13 (24) |
Medications, n(%)a | |
Beta-blockers | 39 (100%) |
Amiodarone | 7 (18%) |
Digoxin | 12 (31%) |
ACEI or ARB | 37 (95%) |
Mineralocorticoid antagonist | 29 (74%) |
Furosemide | 24 (62%) |